Clinical Trials Browser

Phase 1 × Panitumumab × Head & Neck × Clear all

NCT05747625 2026-05-08

(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma

Phase 1 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT05901545 2026-03-05

Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer

Phase 1 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT03733210 2023-05-19

Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer

Phase 1 Completed

14 enrolled 12 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00513383 2017-03-01

Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Adenosquamous